Learn about the latest advances in inflammatory bowel disease (IBD) and advanced endoscopic procedures from the experts of the Dr. Henry D. Janowitz Division of Gastroenterology at Mount Sinai. Ever since Mount Sinai physician Burrill Crohn, MD, and colleagues described the condition now known as Crohn’s disease, Mount Sinai gastroenterologists have been on the cutting edge of diagnosing and treating IBD and other gastrointestinal disorders. Bruce Sands, MD, MS is the Chief of the Division of Gastroenterology and Director of the Digestive Disease Institute. A longtime advocate for the continued translational research in Crohn's disease and ulcerative colitis, Dr. Sands is widely recognized for his innovative treatment of IBD and for his clinical investigations of new therapeutics. Our Susan and Leonard Feinstein IBD Clinical Center, led by Jean-Frederic Colombel, MD, and Marla Dubinsky, MD, is at the forefront of research into the causes of IBD and leads the field in clinical trials that have advanced patient care. Additionally, at our Center for Advanced Colonoscopy and Therapeutic Endoscopy at Sinai (CACTES), led by Christopher DiMaio, MD, our physicians are pioneering new tools and techniques to identify, diagnose, and treat the most complex digestive disorders.
Referring a patient is easy. Just click the “Refer a Patient Online” button.
Latest Videos| View More >
See what makes our Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center unique.
Advances in FMT
The founders of Trellus Health, LLC, discuss their resiliency-driven approach to inflammatory bowel disease treatment utilizing digital tools, care coordination, and support
Dr. J. Antonio Quiros discusses the Pediatric Therapeutic Endoscopy Program at Mount Sinai
Listen as David Dunkin, MD, discusses the advanced and innovative pediatric gastroenterology care provided at Mount Sinai Doctors-Brooklyn Heights
Joanne Lai, MD, discusses the range of pediatric gastroenterology services offered at Mount Sinai Doctors-Long Island.
Helping patients with IBD
Personalizing IBD treatment
Understanding IBD and the microbiome
Managing Crohn's disease
The Future of IBD treatment
Helping patients with pancreatitis
African Americans experience low rates of colorectal cancer screening
Advances in Barrett's Esophagus
Colon cancer screening: what to look for
We launched a database called SECURE-IBD that has already yielded the insight that TNF antagonists appear to be a low-risk IBD therapy where COVID-19 is concerned, and another study, called ICARUS, intended to explore the seroprevalence ...
Gastroenterology and Mount Sinai Heart are among the specialties recognized at The Mount Sinai Hospital in Newsweek’s “The World’s Best Specialized Hospitals 2021.”
COVID-19 Vaccines for IBD Patients: International Consensus
The Icahn School of Medicine at Mount Sinai was ranked No. 3 in the world in U.S. News & World Report “Best University for Gastroenterology and Hepatology.” The Seventh Annual U.S. News & World Report “Best Global Universities” rankings ...
Deirdre J. Cohen, MD, MS, an expert in pancreatic and other gastrointestinal cancers, has joined Mount Sinai Health System as Director of the Gastrointestinal Oncology Program
In the first clinical trial to evaluate two biologic therapies for moderate to severe ulcerative colitis (UC) head to head, Mount Sinai researchers found vedolizumab to be superior to adalimumab in a variety of measures.
Ustekinumab is more effective than placebo as an induction and maintenance therapy for UC.
New research in the disruptions in the GI tract of HIV-1 patients
Population analysis on IBD in Western Countries
Study of infants born to mothers with IBD